Morgan Stanley (MS) Stock Forecast
Data as of Oct 31, 2026Financial Services · Current price $183.28 (-3.54%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 16, 2026 | Mike Mayo | Wells Fargo | $200.00 | +9.1% |
| Apr 16, 2026 | Richard Ramsden | Morgan Stanley | $205.00 | +11.9% |
| Apr 16, 2026 | Ebrahim Poonawala | Morgan Stanley | $225.00 | +22.8% |
| Apr 16, 2026 | Jason Goldberg | Morgan Stanley | $230.00 | +25.5% |
| Apr 16, 2026 | Christopher McGratty | Morgan Stanley | $218.00 | +18.9% |
| Jan 16, 2026 | Gerald Cassidy | RBC Capital | $207.00 | +12.9% |
| Jan 7, 2026 | Steven Chubak | Wolfe Research | $211.00 | +15.1% |
| Jan 7, 2026 | Saul Martinez | Morgan Stanley | $132.00 | -28.0% |
| Nov 24, 2025 | Steven Chubak | Wolfe Research | $198.00 | +8.0% |
| Oct 17, 2025 | Christopher McGratty | Morgan Stanley | $184.00 | +0.4% |
| Oct 16, 2025 | Mike Mayo | Wells Fargo | $177.00 | -3.4% |
| Oct 7, 2025 | Erika Najarian | UBS | $165.00 | -10.0% |
| Sep 30, 2025 | Glenn Schorr | Morgan Stanley | $165.00 | -10.0% |
| May 16, 2025 | Megan Alexander | Morgan Stanley | $53.00 | -71.1% |
| May 16, 2025 | John Baumgartner | Mizuho Securities | $60.00 | -67.3% |
| Oct 17, 2024 | Gerard Cassidy | RBC Capital | $122.00 | -33.4% |
| Oct 17, 2024 | Michael Brown | Wells Fargo | $107.00 | -41.6% |
| Oct 17, 2024 | Glenn Schorr | Morgan Stanley | $133.00 | -27.4% |
| Oct 17, 2024 | Jason Goldberg | Morgan Stanley | $135.00 | -26.3% |
| Oct 4, 2024 | Robert Kad | Williams Trading | $58.00 | -68.4% |
Top Analysts Covering MS
MS vs Sector & Market
| Metric | MS | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.58 | 2.51 | 2.41 |
| Analyst Count | 33 | 9 | 19 |
| Target Upside | +15.7% | +132.9% | +21.5% |
| P/E Ratio | 16.66 | -4.34 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $75.68B | $77.53B | $79.88B | 11 |
| 2027-12-31 | $78.35B | $81.42B | $84.86B | 11 |
| 2028-03-31 | $22.52B | $23.21B | $23.85B | 2 |
| 2028-06-30 | $21.18B | $21.82B | $22.43B | 5 |
| 2028-09-30 | $21.85B | $22.52B | $23.15B | 4 |
| 2028-12-31 | $21.68B | $22.34B | $22.96B | 4 |
| 2029-03-31 | $24.79B | $25.54B | $26.26B | 5 |
| 2029-06-30 | $23.05B | $23.75B | $24.41B | 3 |
| 2029-09-30 | $23.40B | $24.12B | $24.79B | 3 |
| 2029-12-31 | $23.79B | $24.52B | $25.20B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.37 | $11.82 | $12.30 | 16 |
| 2027-12-31 | $12.36 | $12.75 | $13.14 | 16 |
| 2028-03-31 | $3.70 | $3.85 | $3.99 | 4 |
| 2028-06-30 | $3.22 | $3.35 | $3.47 | 4 |
| 2028-09-30 | $3.35 | $3.48 | $3.61 | 6 |
| 2028-12-31 | $3.31 | $3.44 | $3.56 | 4 |
| 2029-03-31 | $4.44 | $4.62 | $4.79 | 3 |
| 2029-06-30 | $3.73 | $3.88 | $4.02 | 3 |
| 2029-09-30 | $3.79 | $3.95 | $4.09 | 6 |
| 2029-12-31 | $3.88 | $4.03 | $4.18 | 3 |
Frequently Asked Questions
What is the analyst consensus for MS?
The consensus among 33 analysts covering Morgan Stanley (MS) is Hold with an average price target of $239.50.
What is the highest price target for MS?
The highest price target for MS is $230.00, set by Jason Goldberg at Morgan Stanley on 2026-04-16.
What is the lowest price target for MS?
The lowest price target for MS is $50.00, set by Youssef Squali at Truist Financial on 2022-04-22.
How many analysts cover MS?
33 analysts have issued ratings for Morgan Stanley in the past 12 months.
Is MS a buy or sell right now?
Based on 33 analyst ratings, MS has a consensus rating of Hold (2.58/5) with a +15.7% upside to the consensus target of $239.50.
What are the earnings estimates for MS?
Analysts estimate MS will report EPS of $11.82 for the period ending 2026-12-31, with revenue estimated at $77.53B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.